title: Morphological features of cat cervicothalamic tract terminations in different target regions.
abstract: Using biotinylated dextran amine to label cervicothalamic tract terminations of cats, three types of terminal arrangements were recognized. The ventral posterior lateral nucleus contains the largest proportion of the cervicothalamic tract terminals (79%) and most (72%) of these are type I terminals (form compact clusters of 5-30 boutons). In contrast, type II (form less compact clusters of 3-10 boutons) and type III (widely spaced boutons along thin axons) terminals dominate in the medial nucleus of the posterior complex (78%) and in the ventral periphery of the ventrobasal complex (86%). In the magnocellular medial geniculate nucleus, type I terminals (38%) are found close to medially located clusters of Cat-301 immunoreactive neurons, whereas type II and type III terminals locate in the surrounding Cat-301-negative regions. These findings indicate a high degree of synaptic security in the transmission between cervicothalamic tract fibers and neurons in the ventral posterior lateral nucleus and highlight the role of this nucleus in faithful transmission of cervicothalamic tract input to the cerebral cortex. Also, the Cat-301-positive neurons in the magnocellular medial geniculate nucleus may faithfully transmit cervicothalamic tract signals. The domination of type II and type III terminals in the medial nucleus of the posterior complex and in the ventral periphery of the ventrobasal complex indicates a more divergent cervicothalamic input to these regions, in line with the large receptive fields and multimodal responses of neurons in the posterior complex.
authors.affiliation: Department of Physiological Sciences, Lund University, Sölvegatan 19, S-223 62 Lund, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Zhang
authors.forename: J
authors.initials: J
authors.lastname: Broman
mesh_terms: D000818:Animals; D001710:Biotin / Q000031:analogs & derivatives* / Q000494:pharmacology; D002415:Cats; D003911:Dextrans / Q000494:pharmacology; D005456:Fluorescent Dyes / Q000494:pharmacology; D008465:Mechanoreceptors / Q000166:cytology / Q000502:physiology; D009434:Neural Pathways / Q000166:cytology* / Q000502:physiology; D020656:Posterior Thalamic Nuclei / Q000166:cytology / Q000502:physiology; D017729:Presynaptic Terminals / Q000145:classification / Q000502:physiology / Q000648:ultrastructure*; D013116:Spinal Cord / Q000166:cytology* / Q000502:physiology; D013788:Thalamus / Q000166:cytology* / Q000502:physiology; D020651:Ventral Thalamic Nuclei / Q000166:cytology / Q000502:physiology
chemical_list: D003911:Dextrans; D005456:Fluorescent Dyes; C076397:biotinylated dextran amine; D001710:Biotin